• Chethan Machaknur

50% of our covid vaccines will be for India, people won't have to buy them, govt will pay


A Day after the Lancet published the first human trial data of the Covid-19 vaccine that is being developed by the Oxford University, Serum Institute of India CEO Adar Poonawalla said 50 per cent of the vaccines that will be manufactured by his firm will be supplied to India and the rest to other countries. Poonawalla said the vaccine will mostly be purchased by the government, and people will receive them free of cost through immunisation programmes.


Adar Poonawalla said if the vaccine trials go fine and the results are favourable, Serum Institute of India will be manufacturing this vaccine as a partner with Oxford University. He said the firm is also seeking regulatory clearances to conduct Phase 3 human trials of the Oxford University vaccine in India so that the vaccine can be manufactured at mass scale if the results are favourable.

6 views
  • Amazon Social Icon
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Instagram

© 2020 by StartupNews. Proudly created in India